GlassScriptAlphalok Recon - R&D
Payments companies reported to CMS as associated with Alphalok Recon - R&D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alphalok Recon - R&D, per program year, as reported to CMS.
Who makes it
- Vilex LLC $160K associated with Alphalok Recon - R&D (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alphalok Recon - R&D
These are the largest totals companies reported as associated with Alphalok Recon - R&D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Anderson | Alamogordo, NM | Podiatrist | $53,526.80 |
| Jeffrey Loveland | Sparta, TN | Podiatrist | $52,758.65 |
| Spencer Monaco | West Chester, PA | Foot & Ankle Surgery | $51,875.44 |
| Sofie Pinney | Cynthiana, KY | Foot & Ankle Surgery | $1,350.00 |
| Charles Sisovsky | Newburgh, IN | Foot & Ankle Surgery | $400.00 |
Prescribed Alphalok Recon - R&D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.